US regulation of plant-made biopharmaceuticals: Part 1

BioPharm International

Volumn 18, Issue 1, 2005, Pages 38-47

  Berberich, Sharon A ^a   Devine, Rebecca A ^b  

^a Chloroen Inc   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT;

BIOTECHNOLOGY; CELL CULTURE; COST BENEFIT ANALYSIS; DRUG APPROVAL; DRUG INDUSTRY; DRUG MANUFACTURE; ENVIRONMENTAL PROTECTION; FOOD AND DRUG ADMINISTRATION; HEALTH CARE POLICY; HEALTH HAZARD; HUMAN; MEDICINAL PLANT; NONHUMAN; PROTEIN EXPRESSION; QUALITY CONTROL; REVIEW;

EID: 16844374535     PISSN: 1542166X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (37)

1. Chovav M, et. al. Q-Series: the state of biomanufacturing. Compiled by DBS Investment Research. 2003 20 June; Available at: www.ubs.com/ investmentresearch.
2. Flinn J, Zavon J. Green plants as biofactories for drugs. BioPharm International 2004 Aug; 17(8):42-49.
3. DePalma A. Is a green plant in your manufacturing future? BioPharm International 2003 Nov; 16(11):24-33.
4. Schillberg S, et al. Antibody molecular farming in plants and plant cells. Phytochemistry Reviews 2002; 1:45-54.
5. Russell DA. Feasibility of antibody production in plants for human therapeutic use. In Hammond J, et al., editors. Current topics in microbiology and immunology: plant biotechnology: new products and applications. Vol. 240. Berlin: Springer-Verlag; 1999. p. 119-138.
6. Biotechnology Industry Organization. Plant-made pharmaceuticals: frequently asked questions Available at: www.bio.org/healthcare/pharmaceutical/ pmp/factsheet2.asp.
7. Ma J K-C, et al. The production of recombinant pharmaceutical proteins in plants. Nature Reviews 2003 Oct; 4:794-805.
8. OST. Proposal for a coordinated framework for regulation of biotechnology. Federal Register 1984; 49 FR 50857.
9. FDA. Guidance for industry, botanical drug products. Available at: www.fda.gov/cder/guidance/4592fnl.htm.
10. USDA. Introduction of organisms and products altered or produced through genetic engineering which are plant pests or which there is reason to believe are plant pests. Federal Register 1987; 52 FR 115.
11. USDA. Genetically engineered organisms and products; notification procedures for the introduction of certain regulated articles: and petition for nonregulated status. Federal Register 1993; 58 FR 60.
12. USDA. Simplification of requirements and procedures for genetically engineered organisms and products. Federal Register 1997; 62 FR 85.
13. USDA. Current status of petitions and permits. Available at: www.aphis.usda.gov/brs/status/petday.html.
14. National Environmental Policy Act of 1969. (Pub. L. 91-190, 42 USC 4321-4347, January 1, 1970, as amended by Pub. L. 94-52, July 3, 1975, Pub. L. 94-83, August 9, 1975, and Pub. L. 97-258, § 4(b), Sept. 13, 1982).
15. Public Health Service Act. Section 351. 42 USC 201.
16. Federal Food Drug and Cosmetic Act. Section 201(g). 42 USC 262.
17. Code of Federal Regulations. Good laboratory practice. 21 CFR Part 58.
18. Code of Federal Regulations 21CFR Parts 210, 211, 600. 21 Part 210 available at: www.access.gpo.gov/nara/cfr/waisidx_02/21cfr210_02.html. Part 211 available at:. www.access.gpo.gov/nara/cfr/waisidx_02/21cfr211_02.html. Part 600 available at: www.access.gpo.gov/nara/cfr/waisidx_02/21cfr600_02.html.
19. FDA Modernization Act of 1997, Modernization of regulation. Section 123.
20. Code of Federal Regulations. Investigational new drug application. 21 CFR Part 312.
21. Plant Protection Act of 2000. 7 USC 7701-7758. Available at: www.aphis.usda.gov/ppq/weeds/PPAText.pdf
22. Code of Federal Regulations. 7 CFR Part 330. Federal plant pest regulations, general plant pests, soil, stone and quarry products, garbage. 7 CFR Part 340. Introduction of organisms and products altered or produced through genetic engineering which are plant pests or which there is a reason to believe are plant pests.
23. EPA. Environmental impact statement: introduction of genetically engineered organisms. Federal Register 2004; 69 FR 3271.
24. USDA. Dear permit applicant letter. Available at: www.aphis.usda.gov/brs/ pdf/011404.pdf.
25. Federal insecticide, fungicide, and rodenticide act. 1996; 7 USC 136a. Available at: www.epa.gov/region5/defs/html/fifra.htm.
26. Federal food drug and cosmetic act. Section 408. 21 USC 346a. Available at: www.access.gpo.gov/uscode/title21/chapter9_.html.
27. Code of Federal Regulations. Final regulations for plant-pesticides. Title 40 Part 174.
28. Code of Federal Regulations. Environmental impact considerations. Title 21 Part 25.
29. USC Title 15 Part 53. Control of Toxic Substances.
30. EPA. Full text of TSCA available at: www4.law.cornell.edu/uscode/15/ch53. html.
31. Code of Federal Regulations. Licensing. 21 CFR Part 601.
32. Code of Federal Regulations. Applications for FDA approval to market a new drug. 21 CFR Part 314.
33. Federal food drug and cosmetic act, Section 505. 21 USC 9. Available at: www.access.gpo.gov/uscode/title21/chapter9_.html.
34. FDA. Draft guidance for industry: drugs, biologics, and medical devices derived from bioengineered plants for use in humans and animals. Available at: www.fda.gov/OHRMS/DOCKETS/98fr/02d-0324-gdl0001.pdf.
35. Code of Federal Regulations. IND content and format. 21 CFR Part 312.23.
36. USDA. Application for permit or courtesy permit Under 7 CFR 340. Available at: www.aphis.usda.gov/forms/2000.pdf
37. USDA. Release permits for pharmaceuticals, industrials, value added proteins for human consumption, or for phytoremediation granted or pending by APHIS as of 2004 November 17. Available at: www.aphis.usda.gov/brs/ph_permits. html.